Pozo CM, Capote PLL, Ríos MR, Reyes HD

Language: Spanish
References: 12
Page: 428-434
PDF size: 77.72 Kb.

ABSTRACT

Introduction: initial evaluation of the severity of a patient with communityacquired pneumonia is the key to set treatment and the most adequate behavior for his/her care.
Objective: to evaluate through the CRB65 scale the initial management and the clinical behavior of patients with community-acquired pneumonia, who were admitted to ¨Luis Diaz Soto¨ central military hospital.
Methods: retrospective, observational and cross-sectional study of 172 patients diagnosed with community-acquired pneumonia, who were hospitalized in the period of 2011 to 2013 and were applied the prognostic test CRB65. The admission criteria were evaluated for each type of hospitalization ward for which criteria of ¨good¨or ¨bad¨location in wards were devised. The main output variables were mortality and complications.
Results: the ¨wrongly located¨ patients were more likely to present complications, either those staying in the minimal care unit or those in the intensive care unit (OR: 20.24 and OR: 11.56 respectively, p ‹ 0,001).
Conclusions: the CRB65 scale is a useful tool allowing a better clinical management of hospitalized patients with community-acquired pneumonia and its use avoids making wrong decisions about hospitalization and location of patients according to a severity criterion, so it reduces the occurrence of complications and mortality from this disease.

REFERENCES

1. Dean NC, Bateman KA, Donnelly SM, Silver MP, Snow GL, Hale D . Improved Clinical Outcomes with Utilization of a Community-Acquired Pneumonia Guideline. CHEST 2006 [cited 2009 Nov 11];130(3):794-9. Disponible en: http://journal.publications.chestnet.org/article.aspx?articleid=1084659

2. Menendez R. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Tórax 2004;59:960-5.

3. Capelastegui A, España PP, Quintana JM, Gorordo I, Sañudo C, Bilbao A. Evaluación de la práctica clínica en los pacientes ingresados por neumonía adquirida en la comunidad durante un período de 4 años. Arch Bronconeumol. 2006;42:283-9.

4. Jokinen C, Heiskanen L, Juvonen H, Kallinen S, Karkola K, Korppi M, et al. Incidence of community-acquired neumonía in the population of four municipalities in eastern Finland. Am J Epidemiol. 1993;137:977-88.

5. Alkhayer M., Jenkins P.F., Harrison B.D. The outcome of community acquired pneumonia treated on the intensive care unit. Repir Med 1990;84:13-6.

6. Almirall J, Bolíbar I, Vidal J, Sauca G, Coll P, Niklasson B, et-al. Epidemiology of community-acquired pneumonia in adults: a population-based study. Eur Respir J. 2000;15:757-63.

7. Castro-Guardiola A, Armengou A, García D, Viejo A, Obón M, García-Bragado F. Prospective study of 198 community acquired pneumonias in a general hospital]. Enferm Infecc Microbiol Clin. 1999 May;17(5):213-8.

8. Rosón B, Carratalà J, Fernández-Sabé N., Tubau F, Manresa F, Gudiol F. Causes and factors associated with early failure in hospitalized patients with communityacquired pneumonia. J Arch Intern Med. 2004;164:502-8.

9. Alkhayer M, Jenkins PF, Harrison BD. The outcome of community acquired pneumonia treated on the intensive care unit. Repir Med. 1990;84:13-6.

10. Mortensen EM, Kapoor WN, Chang CC, Fine MJ. Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia. Clin Infect Dis. 2003;37:1617-24.

11. Ewig S, Schafer H, Torres A. Severity assessment in community-acquired pneumonia. Eur Respir J. 2000;16:1193-201.

12. Valencia M, Badia JR, Cavalcanti M, Ferrer M, Agustí C, Angrill J, et al. Pneumonia Severity Index Class V Patients With Community-Acquired Pneumonia: Characteristic, outcomes and value of severity scores 2007. Chest 2009 Nov 1 [cited 2009 Nov 11];136(5 Suppl):e30. Disponible en: http://journal.publications.chestnet.org/article.aspx?articleid=1085296